Knight Therapeutics Assumes Commercial Activities for Exelon in Colombia
MONTREAL, June 01, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Colombian affiliate, Biotoscana Farma S.A., is in the process of assuming full commercial activities for Exelon ® (rivastigmine) in Colombia upon successful transfer of the marketing authorization.
Knight Therapeutics Assumes Commercial Activities for Exelon in Colombia
MONTREAL, June 01, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Colombian affiliate, Biotoscana Farma S.A., is in the process of assuming full commercial activities for Exelon ® (rivastigmine) in Colombia upon successful transfer of the marketing authorization.